The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive treatment of episodic migraine.

Firstsource Solutions Ltd., incorporated in the year 2001, is a Mid Cap company (having a market cap of Rs 23,533.90 Crore) operating in IT Enabled Services sector. Firstsource Solutions Ltd. key ...

Click Therapeutics has collected a groundbreaking green light from the FDA for the agency’s first prescription digital ...

Report Ocean’s recent report provides an accurate and comprehensive research analysis of the “Saudi Arabia Migraine Therapeutics Market ... and growth prospects of the patient engagement solutions ...

If approved, AJOVY would be the only calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pediatric patients, helping to address ...

Migraine symptoms typically last between one and three days; rarely, people feel effects for a week or more. Some people with migraines experience an aura 10 minutes to an hour before the headache; ...

In these days of combing online imagery for symptoms of genAI “hallucination”, it’s easy to forget that once upon a time, mutant video game visuals were beautiful. There's a whole genre of art ...

Background Migraine and Persistent Postural Perceptual Dizziness (PPPD) are two diagnostically challenging causes of episodic vertigo. We aim to describe and compare the Niigata PPPD Questionnaire ...

“Throughout my journey, I couldn’t expose my scalp. Whenever I used to remove my cap or my wig, I felt migraine within 20-30 minutes. I used to have migraines that lasted for days together. This is ...

Please view our affiliate disclosure. In the fast-paced digital era, businesses are constantly seeking innovative solutions to streamline their document management processes. As artificial ...